Maybe the JCVI decision does make sense. Thread.
I've revisited their terms of reference. They're all about cost-effectiveness.
gov.uk/government/gro…
I've revisited their terms of reference. They're all about cost-effectiveness.
gov.uk/government/gro…
They appear to have framed the benefits of vaccinating 12-15-yos exclusively in terms of the short term healthcare costs that would be avoided.
They appear not to have considered the wider benefits to children's.
Such as a reduction in disruption to education.
They appear not to have considered the wider benefits to children's.
Such as a reduction in disruption to education.
Such as distress when parents or grandparents get ill, can't work/earn due to Long Covid, or die.
Or the harm to the 1 in 7 children who get Long Covid, or the minority with permanent organ damage.
Or the harm to the 1 in 7 children who get Long Covid, or the minority with permanent organ damage.
By ignoring all these benefits and only looking at the short-term costs to the health service of treating the initial illness,
they're found that there is a benefit to vaccinating 12 to 15-year olds, but it doesn't meet the NICE cost-effectiveness threshold.
they're found that there is a benefit to vaccinating 12 to 15-year olds, but it doesn't meet the NICE cost-effectiveness threshold.
We've been here before. When a vaccine was introduced against Group B meningococcal disease it was expensive, and not initially thought to be cost-effective.
They subsequently revisited the costs, and included the long-term costs of the people who have the disease and survive, but with permanent impairments.
Deafness, blindness, intellectual impairment, amputations, and so on.
Deafness, blindness, intellectual impairment, amputations, and so on.
When they looked at the costs of caring for people with these conditions, and the loss of their contribution to the economy through employment and taxation, caring, and so on, they soon found that the benefits of vaccination were worth more than the costs of the vaccination…
…programme.
In the meantime, however children, missed out on this meningococcal vaccine.
In the meantime, however children, missed out on this meningococcal vaccine.
We are staring down the barrels of the highly transmissible delta variant gun, and of the other more virulent or more transmissible variants that may arise if we do not control the virus as quickly as possible.
We do not have time to specify the value of the benefits of vaccination the last few £100 before making her decision to implement the vaccine.
End of thread.
End of thread.
@threadreaderapp unroll
My apologies for the typos - tweeting and exercise don't go well together. The brain works; the typing fingers and proof-reading don't!
ps Initially I wasn't convinced the economic case for introducing so-called meningococcal group B vaccines had been made.
drugsincontext.com/individual/vac…
drugsincontext.com/individual/vac…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
